Showing results (71-80 of 373) with videos related to
Sort By:
Pageof 38
Current Opinion in Urology|July 1, 2015
How should clinicians address intratumour heterogeneity in clear cell renal cell carcinoma?Aspasia Soultati, Mark Stares, Charles Swanton, et al.Cancer Discovery|June 21, 2015
APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and HeterogeneityCharles Swanton, Nicholas McGranahan, Gabriel J Starrett, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2015
Translational implications of tumor heterogeneityMariam Jamal-Hanjani, Sergio A Quezada, James Larkin, et al.Genome Biology|September 16, 2014
Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicineCrispin Hiley, Elza C de Bruin, Nicholas McGranahan, et al.Cell Cycle (Georgetown, Tex.)|August 28, 2007
Initiation of high frequency multi-drug resistance following kinase targeting by siRNAsCharles Swanton, Barbara Nicke, Michela Marani, et al.Cancer Prevention Research (Philadelphia, Pa.)|March 17, 2023
Clonal Evolution in Healthy and Premalignant Tissues: Implications for Early Cancer Interception StrategiesJayant K Rane, Alexander M Frankell, Clare E Weeden, et al.European Journal of Cancer (Oxford, England : 1990)|April 24, 2010
Anti-cancer drug resistance: understanding the mechanisms through the use of integrative genomics and functional RNA interferenceDaniel S-W Tan, Marco Gerlinger, Bin-Tean Teh, et al.Trends in Cancer|April 14, 2023
Insights into the metastatic cascade through research autopsiesSonya Hessey, Petros Fessas, Simone Zaccaria, et al.Scientific Reports|December 4, 2013
Computational optimisation of targeted DNA sequencing for cancer detectionPierre Martinez, Nicholas McGranahan, Nicolai Juul Birkbak, et al.Nature Reviews. Urology|January 18, 2012
Epigenetic regulation in RCC: opportunities for therapeutic intervention?James Larkin, Xin Yi Goh, Marcus Vetter, et al.Pageof 38